Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Cash Conversion Cycle: 171.99 (As of Mar. 2026)


STC:DBD Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
82 GF Score
Price ₫53,200.00
GF Value ₫52,212.47
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Conversion Cycle?

Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD +2.90% 82 Cash Conversion Cycle is 171.99 as of Mar. 2026. GuruFocus rates STC:DBD with a GF Score™ of 82/100 and a GF Value™ of ₫52,212.47 (Fairly Valued). The stock has 3 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Sales Outstanding for the three months ended in Mar. 2026 was 102.77.
Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Inventory for the three months ended in Mar. 2026 was 147.18.
Binh Dinh Pharmaceutical And Medical Equipment JSC's Days Payable for the three months ended in Mar. 2026 was 77.96.
Therefore, Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2026 was 171.99.


Binh Dinh Pharmaceutical And Medical Equipment JSC  (STC:DBD) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Conversion Cycle Related Terms


Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Conversion Cycle Chart

Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Conversion Cycle
Get a 7-Day Free Trial 159.04 225.70 254.71 250.27 189.55

Binh Dinh Pharmaceutical And Medical Equipment JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.99 243.18 210.04 148.07 171.99

STC:DBD vs ZTS: Cash Conversion Cycle Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Conversion Cycle vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle falls into.


STC:DBD
82GF Score
Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Binh Dinh Pharmaceutical And Medical Equipment JSC Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=97.86+162.13-70.44
=189.55

Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle for the quarter that ended in Mar. 2026 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=102.77+147.18-77.96
=171.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 171.99 mean?
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a Cash Conversion Cycle of 171.99 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current Cash Conversion Cycle is 171.99. The Drug Manufacturers industry median Cash Conversion Cycle is 145.82. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 171.99 is 17.9% above this industry median. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle compare to ZTS?
Binh Dinh Pharmaceutical And Medical Equipment JSC's Cash Conversion Cycle of 171.99 can be compared against companies in the Drug Manufacturers industry. The industry median Cash Conversion Cycle is 145.82. Binh Dinh Pharmaceutical And Medical Equipment JSC's value of 171.99 is 17.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Drug Manufacturers company?
The median Cash Conversion Cycle among Drug Manufacturers companies is 145.82, based on 947 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Cash Conversion Cycle of 171.99 is 17.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. For the Drug Manufacturers industry, the median Cash Conversion Cycle is 145.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Binh Dinh Pharmaceutical And Medical Equipment JSC's current Cash Conversion Cycle is 171.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,212.47, compared to a current price of ₫53,200.00 — trading 1.9% above its estimated fair value. The current Cash Conversion Cycle is 171.99 and 17.9% above the Drug Manufacturers industry median of 145.82. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current Cash Conversion Cycle is 171.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?

Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be overvalued. The current stock price of ₫53,200.00 is trading 1.9% above its estimated GF Value™ of ₫52,212.47. GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.

Key valuation signals for STC:DBD:

  • Cash Conversion Cycle: 171.99
  • GF Value™: ₫52,212.47 vs. price of ₫53,200.00 (1.9% above fair value)
  • GF Score™: 82/100 with 3 warning signs
  • Industry Position: 17.9% above the Drug Manufacturers median

No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description

Address 498 Nguyen Thai Hoc Street, Quang Trung Ward, Binh Dinh Province, Quy Nhon, VNM
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
82GF Score

Get the complete analysis for STC:DBD

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫53,200.00
Price
₫52,212.47
GF Value